Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

Publisher： Karger

E-ISSN： 1421-9662|132|2|211-219

ISSN： 0001-5792

Source： Acta Haematologica, Vol.132, Iss.2, 2014-03, pp. : 211-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 109-114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

By  

Acta Haematologica, Vol. 137, Iss. 3, 2017-04 ,pp. : 163-172

Karger

Access to resources Recommend Favorite

Incidence and Risk Factors of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients Having Undergone Autologous Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 658-664

Karger

Access to resources Recommend Favorite

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2709-2713

John Wiley & Sons Inc

Access to resources Recommend Favorite

Poor peripheral blood stem cell mobilization affects long‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 33, Iss. 1, 2018-02 ,pp. : 29-37

John Wiley & Sons Inc

Access to resources Recommend Favorite